Navigation Links
iCardiac Doubles Quarterly Revenues and Garners Innovation Recognition
Date:12/12/2012

Rochester, NY (PRWEB) December 12, 2012

Today, iCardiac Technologies, Inc., a leading global provider of cardiac safety assessment services, announced that the company doubled its fiscal first quarter revenues for the period ending September 30th, 2012. The new customer growth reflects iCardiac’s innovation around improving the precision of key cardiac safety measurements. This same innovation was recently recognized by local government officials as part of their promotion of more innovation nationally. This recognition follows iCardiac’s honor of being listed on the Science Coalition 100 of the nation’s 100 great technology transfer success stories and also as one of the fastest growing companies in Rochester, NY as determined by the Democrat & Chronicle.

“These honors, both locally and nationally, reflect iCardiac’s robust growth, which is tied to our solid commitment to client satisfaction in cardiac safety analysis,” said Mikael Totterman, chief executive officer of iCardiac. “Our team is growing and our company is poised for continued growth in 2013.”

iCardiac Technologies now serves 7 of the world’s 10 largest pharmaceutical companies, as well as numerous medium and small biotech, pharmaceutical and medical device clients.

About iCardiac
iCardiac Technologies is a global cardiac safety company that has commercialized advanced research originating at leading academic institutions and pharmaceutical companies. Its reach is international, working with pharmaceutical and medical device clients all over the world to bring the best results to cardiac safety. For more information visit: http://www.icardiac.com/.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10199599.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
2. CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2012
3. PDL BioPharma Completes Regular Quarterly Dividend Payment
4. Cord Blood America Revenues Up 37 Percent to $5.67 Million in 2011
5. CitiusTech Completes Another Milestone Year: Revenues Grow by 59% in 2011
6. iLuv Earns International Acclaim for Excellence and Innovation in Product Design
7. Bayer CropScience Provides a Glimpse of SeedGrowth™ Innovation
8. NineSigma Engages AtriCure in the Ohio Third Frontier Open Innovation Incentive Program
9. The Scientist Proudly Announces the Top 10 Innovations of 2012
10. Marrone Bio Innovations’ CEO to Address European Biopesticide Industry at Informa Life Sciences Biopesticides Conference
11. CHTF 2012 Opens: Innovation Is A Key Theme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , Jan. 20, 2017 Ginkgo ... of Gen9, a pioneer in the synthesis and ... unique expertise in assembling pathway-length synthetic DNA into ... and capacity in the construction of new organism ... industries. "Gen9 was founded to significantly ...
(Date:1/19/2017)... Jan 19, 2017 Research and Markets has ... Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry ... ... the global market is projected to reach $15,737 million by 2022 ... 2016 to 2022. Omic technologies segment accounted for ...
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research ... leading biopharmaceutical and medical device manufacturers and regulators, is proud to announce the ... 11-compliant email client designed to provide product vigilance departments with the flexibility and ...
Breaking Biology Technology:
(Date:12/22/2016)... 2016  As part of its longstanding mission to improve ... company, recently released its latest children,s book, titled ... on the topics of inheritance and variation of traits that ... in elementary school classrooms in the US. ... Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/15/2016)... , December 15, 2016 Arvato ... an agreement with NuData Security, an award-winning international ... will enable clients to focus on good customer experience, balancing ... regulation. ... In order to provide a one-stop fraud prevention suite, Arvato ...
Breaking Biology News(10 mins):